nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—Carboplatin—breast cancer	0.227	1	CbGbCtD
Propylthiouracil—TPO—adipose tissue—breast cancer	0.00543	0.132	CbGeAlD
Propylthiouracil—TPO—adrenal gland—breast cancer	0.00487	0.119	CbGeAlD
Propylthiouracil—TPO—endocrine gland—breast cancer	0.00423	0.103	CbGeAlD
Propylthiouracil—DBH—female reproductive system—breast cancer	0.00326	0.0794	CbGeAlD
Propylthiouracil—DBH—adrenal gland—breast cancer	0.00318	0.0775	CbGeAlD
Propylthiouracil—DBH—bone marrow—breast cancer	0.00308	0.075	CbGeAlD
Propylthiouracil—DBH—endocrine gland—breast cancer	0.00276	0.0672	CbGeAlD
Propylthiouracil—MPO—epithelium—breast cancer	0.00235	0.0572	CbGeAlD
Propylthiouracil—MPO—skin of body—breast cancer	0.00223	0.0544	CbGeAlD
Propylthiouracil—DBH—lymph node—breast cancer	0.00191	0.0465	CbGeAlD
Propylthiouracil—MPO—pituitary gland—breast cancer	0.0019	0.0464	CbGeAlD
Propylthiouracil—MPO—adrenal gland—breast cancer	0.0017	0.0414	CbGeAlD
Propylthiouracil—MPO—bone marrow—breast cancer	0.00164	0.0401	CbGeAlD
Propylthiouracil—MPO—endocrine gland—breast cancer	0.00147	0.0359	CbGeAlD
Propylthiouracil—MPO—lymph node—breast cancer	0.00102	0.0248	CbGeAlD
Propylthiouracil—Hepatic failure—Epirubicin—breast cancer	0.000426	0.00102	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000426	0.00102	CcSEcCtD
Propylthiouracil—Leukopenia—Fluorouracil—breast cancer	0.000424	0.00101	CcSEcCtD
Propylthiouracil—Myalgia—Mitoxantrone—breast cancer	0.000421	0.00101	CcSEcCtD
Propylthiouracil—Arthralgia—Mitoxantrone—breast cancer	0.000421	0.00101	CcSEcCtD
Propylthiouracil—Paraesthesia—Thiotepa—breast cancer	0.00042	0.001	CcSEcCtD
Propylthiouracil—Somnolence—Thiotepa—breast cancer	0.000416	0.000993	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Doxorubicin—breast cancer	0.000416	0.000993	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Capecitabine—breast cancer	0.000415	0.000993	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—breast cancer	0.000415	0.000991	CcSEcCtD
Propylthiouracil—Jaundice—Capecitabine—breast cancer	0.000413	0.000987	CcSEcCtD
Propylthiouracil—Dyspepsia—Thiotepa—breast cancer	0.000412	0.000984	CcSEcCtD
Propylthiouracil—Arthralgia—Gemcitabine—breast cancer	0.00041	0.00098	CcSEcCtD
Propylthiouracil—Myalgia—Gemcitabine—breast cancer	0.00041	0.00098	CcSEcCtD
Propylthiouracil—Alopecia—Paclitaxel—breast cancer	0.00041	0.000979	CcSEcCtD
Propylthiouracil—Vomiting—Chlorambucil—breast cancer	0.000409	0.000977	CcSEcCtD
Propylthiouracil—Agranulocytosis—Docetaxel—breast cancer	0.000408	0.000976	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—breast cancer	0.000406	0.00097	CcSEcCtD
Propylthiouracil—Pruritus—Tamoxifen—breast cancer	0.000405	0.000968	CcSEcCtD
Propylthiouracil—Oedema—Mitoxantrone—breast cancer	0.000404	0.000965	CcSEcCtD
Propylthiouracil—Oedema—Irinotecan—breast cancer	0.000404	0.000965	CcSEcCtD
Propylthiouracil—Myalgia—Fluorouracil—breast cancer	0.000403	0.000964	CcSEcCtD
Propylthiouracil—Pruritus—Melphalan—breast cancer	0.000397	0.000947	CcSEcCtD
Propylthiouracil—Agranulocytosis—Capecitabine—breast cancer	0.000396	0.000945	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Irinotecan—breast cancer	0.000395	0.000945	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Mitoxantrone—breast cancer	0.000395	0.000945	CcSEcCtD
Propylthiouracil—Dysgeusia—Paclitaxel—breast cancer	0.000395	0.000944	CcSEcCtD
Propylthiouracil—Haemoglobin—Docetaxel—breast cancer	0.000395	0.000944	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—breast cancer	0.000394	0.000942	CcSEcCtD
Propylthiouracil—Oedema—Gemcitabine—breast cancer	0.000393	0.00094	CcSEcCtD
Propylthiouracil—Haemorrhage—Docetaxel—breast cancer	0.000393	0.000939	CcSEcCtD
Propylthiouracil—Hepatitis—Docetaxel—breast cancer	0.000393	0.000939	CcSEcCtD
Propylthiouracil—Urticaria—Vinorelbine—breast cancer	0.000389	0.000929	CcSEcCtD
Propylthiouracil—Body temperature increased—Vinorelbine—breast cancer	0.000387	0.000925	CcSEcCtD
Propylthiouracil—Pruritus—Goserelin—breast cancer	0.000387	0.000924	CcSEcCtD
Propylthiouracil—Oedema—Fluorouracil—breast cancer	0.000387	0.000924	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Gemcitabine—breast cancer	0.000385	0.00092	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—breast cancer	0.000384	0.000917	CcSEcCtD
Propylthiouracil—Haemoglobin—Capecitabine—breast cancer	0.000382	0.000914	CcSEcCtD
Propylthiouracil—Nausea—Chlorambucil—breast cancer	0.000382	0.000913	CcSEcCtD
Propylthiouracil—Hepatitis—Capecitabine—breast cancer	0.00038	0.000909	CcSEcCtD
Propylthiouracil—Haemorrhage—Capecitabine—breast cancer	0.00038	0.000909	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Fluorouracil—breast cancer	0.000379	0.000905	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—breast cancer	0.000376	0.000898	CcSEcCtD
Propylthiouracil—Vomiting—Vinblastine—breast cancer	0.000375	0.000895	CcSEcCtD
Propylthiouracil—Urticaria—Thiotepa—breast cancer	0.000372	0.000888	CcSEcCtD
Propylthiouracil—Body temperature increased—Thiotepa—breast cancer	0.00037	0.000883	CcSEcCtD
Propylthiouracil—Headache—Vinblastine—breast cancer	0.000369	0.000882	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000368	0.000879	CcSEcCtD
Propylthiouracil—Vomiting—Tamoxifen—breast cancer	0.000364	0.00087	CcSEcCtD
Propylthiouracil—Paraesthesia—Mitoxantrone—breast cancer	0.000363	0.000866	CcSEcCtD
Propylthiouracil—Paraesthesia—Irinotecan—breast cancer	0.000363	0.000866	CcSEcCtD
Propylthiouracil—Vertigo—Paclitaxel—breast cancer	0.000363	0.000866	CcSEcCtD
Propylthiouracil—Leukopenia—Paclitaxel—breast cancer	0.000361	0.000863	CcSEcCtD
Propylthiouracil—Rash—Tamoxifen—breast cancer	0.000361	0.000862	CcSEcCtD
Propylthiouracil—Dermatitis—Tamoxifen—breast cancer	0.000361	0.000862	CcSEcCtD
Propylthiouracil—Somnolence—Irinotecan—breast cancer	0.000359	0.000858	CcSEcCtD
Propylthiouracil—Somnolence—Mitoxantrone—breast cancer	0.000359	0.000858	CcSEcCtD
Propylthiouracil—Headache—Tamoxifen—breast cancer	0.000359	0.000857	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000358	0.000856	CcSEcCtD
Propylthiouracil—Vomiting—Melphalan—breast cancer	0.000356	0.000851	CcSEcCtD
Propylthiouracil—Dyspepsia—Irinotecan—breast cancer	0.000356	0.000849	CcSEcCtD
Propylthiouracil—Dyspepsia—Mitoxantrone—breast cancer	0.000356	0.000849	CcSEcCtD
Propylthiouracil—Rash—Melphalan—breast cancer	0.000353	0.000844	CcSEcCtD
Propylthiouracil—Paraesthesia—Gemcitabine—breast cancer	0.000353	0.000844	CcSEcCtD
Propylthiouracil—Dermatitis—Melphalan—breast cancer	0.000353	0.000844	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000352	0.000842	CcSEcCtD
Propylthiouracil—DBH—Metabolism—COX11—breast cancer	0.000352	0.00112	CbGpPWpGaD
Propylthiouracil—Nausea—Vinblastine—breast cancer	0.00035	0.000836	CcSEcCtD
Propylthiouracil—Somnolence—Gemcitabine—breast cancer	0.00035	0.000836	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CHST9—breast cancer	0.000349	0.00111	CbGpPWpGaD
Propylthiouracil—Vomiting—Goserelin—breast cancer	0.000348	0.000831	CcSEcCtD
Propylthiouracil—Paraesthesia—Fluorouracil—breast cancer	0.000347	0.00083	CcSEcCtD
Propylthiouracil—Alopecia—Docetaxel—breast cancer	0.000347	0.00083	CcSEcCtD
Propylthiouracil—Pruritus—Vinorelbine—breast cancer	0.000346	0.000828	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—BCL2—breast cancer	0.000346	0.0011	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL6—breast cancer	0.000345	0.0011	CbGpPWpGaD
Propylthiouracil—Rash—Goserelin—breast cancer	0.000345	0.000824	CcSEcCtD
Propylthiouracil—Dermatitis—Goserelin—breast cancer	0.000344	0.000823	CcSEcCtD
Propylthiouracil—Somnolence—Fluorouracil—breast cancer	0.000344	0.000822	CcSEcCtD
Propylthiouracil—Arthralgia—Paclitaxel—breast cancer	0.000344	0.000821	CcSEcCtD
Propylthiouracil—Myalgia—Paclitaxel—breast cancer	0.000344	0.000821	CcSEcCtD
Propylthiouracil—Headache—Goserelin—breast cancer	0.000343	0.000818	CcSEcCtD
Propylthiouracil—Dyspepsia—Fluorouracil—breast cancer	0.00034	0.000813	CcSEcCtD
Propylthiouracil—Nausea—Tamoxifen—breast cancer	0.00034	0.000812	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CA9—breast cancer	0.00034	0.00108	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTA4—breast cancer	0.00034	0.00108	CbGpPWpGaD
Propylthiouracil—Alopecia—Capecitabine—breast cancer	0.000336	0.000803	CcSEcCtD
Propylthiouracil—Dysgeusia—Docetaxel—breast cancer	0.000335	0.0008	CcSEcCtD
Propylthiouracil—Nausea—Melphalan—breast cancer	0.000333	0.000795	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GPX2—breast cancer	0.000331	0.00106	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTA2—breast cancer	0.000331	0.00106	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—COX11—breast cancer	0.000331	0.00106	CbGpPWpGaD
Propylthiouracil—Pruritus—Thiotepa—breast cancer	0.000331	0.00079	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CD4—breast cancer	0.000331	0.00106	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—TNF—breast cancer	0.00033	0.00105	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IFNG—breast cancer	0.00033	0.00105	CbGpPWpGaD
Propylthiouracil—Oedema—Paclitaxel—breast cancer	0.000329	0.000787	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—PTGS2—breast cancer	0.000328	0.00105	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GPX4—breast cancer	0.000327	0.00104	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SULT1A1—breast cancer	0.000327	0.00104	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—RELA—breast cancer	0.000326	0.00104	CbGpPWpGaD
Propylthiouracil—Nausea—Goserelin—breast cancer	0.000325	0.000776	CcSEcCtD
Propylthiouracil—Dysgeusia—Capecitabine—breast cancer	0.000324	0.000775	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Paclitaxel—breast cancer	0.000322	0.00077	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SHMT1—breast cancer	0.000322	0.00103	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CDA—breast cancer	0.000322	0.00103	CbGpPWpGaD
Propylthiouracil—Urticaria—Mitoxantrone—breast cancer	0.000321	0.000767	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—IDH1—breast cancer	0.000319	0.00102	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTA1—breast cancer	0.000319	0.00102	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Mitoxantrone—breast cancer	0.000319	0.000763	CcSEcCtD
Propylthiouracil—Body temperature increased—Irinotecan—breast cancer	0.000319	0.000763	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—PTGS2—breast cancer	0.000316	0.00101	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NAT2—breast cancer	0.000316	0.00101	CbGpPWpGaD
Propylthiouracil—Drowsiness—Methotrexate—breast cancer	0.000315	0.000754	CcSEcCtD
Propylthiouracil—Vomiting—Vinorelbine—breast cancer	0.000311	0.000744	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1B—breast cancer	0.000311	0.000992	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Gemcitabine—breast cancer	0.000311	0.000743	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SLC2A5—breast cancer	0.00031	0.000989	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLCO1B1—breast cancer	0.00031	0.000989	CbGpPWpGaD
Propylthiouracil—Rash—Vinorelbine—breast cancer	0.000309	0.000738	CcSEcCtD
Propylthiouracil—Dermatitis—Vinorelbine—breast cancer	0.000308	0.000737	CcSEcCtD
Propylthiouracil—Urticaria—Fluorouracil—breast cancer	0.000307	0.000734	CcSEcCtD
Propylthiouracil—Headache—Vinorelbine—breast cancer	0.000307	0.000733	CcSEcCtD
Propylthiouracil—Leukopenia—Docetaxel—breast cancer	0.000306	0.000732	CcSEcCtD
Propylthiouracil—Body temperature increased—Fluorouracil—breast cancer	0.000306	0.000731	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SHMT1—breast cancer	0.000303	0.000966	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CDA—breast cancer	0.000303	0.000966	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.0003	0.000717	CcSEcCtD
Propylthiouracil—DBH—Metabolism—APRT—breast cancer	0.000299	0.000955	CbGpPWpGaD
Propylthiouracil—Vertigo—Capecitabine—breast cancer	0.000298	0.000711	CcSEcCtD
Propylthiouracil—Vomiting—Thiotepa—breast cancer	0.000297	0.00071	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—breast cancer	0.000297	0.000947	CbGpPWpGaD
Propylthiouracil—Leukopenia—Capecitabine—breast cancer	0.000296	0.000708	CcSEcCtD
Propylthiouracil—Paraesthesia—Paclitaxel—breast cancer	0.000296	0.000707	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—breast cancer	0.000295	0.000705	CcSEcCtD
Propylthiouracil—Rash—Thiotepa—breast cancer	0.000295	0.000704	CcSEcCtD
Propylthiouracil—Dermatitis—Thiotepa—breast cancer	0.000295	0.000704	CcSEcCtD
Propylthiouracil—Agranulocytosis—Methotrexate—breast cancer	0.000294	0.000703	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL1B—breast cancer	0.000294	0.000939	CbGpPWpGaD
Propylthiouracil—Headache—Thiotepa—breast cancer	0.000293	0.0007	CcSEcCtD
Propylthiouracil—Somnolence—Paclitaxel—breast cancer	0.000293	0.0007	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SLC2A5—breast cancer	0.000291	0.00093	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLCO1B1—breast cancer	0.000291	0.00093	CbGpPWpGaD
Propylthiouracil—Arthralgia—Docetaxel—breast cancer	0.000291	0.000696	CcSEcCtD
Propylthiouracil—Myalgia—Docetaxel—breast cancer	0.000291	0.000696	CcSEcCtD
Propylthiouracil—Nausea—Vinorelbine—breast cancer	0.000291	0.000695	CcSEcCtD
Propylthiouracil—Dyspepsia—Paclitaxel—breast cancer	0.00029	0.000693	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—breast cancer	0.000289	0.000691	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—breast cancer	0.000288	0.000688	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1A—breast cancer	0.000287	0.000916	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Methotrexate—breast cancer	0.000285	0.00068	CcSEcCtD
Propylthiouracil—Hepatitis—Methotrexate—breast cancer	0.000283	0.000677	CcSEcCtD
Propylthiouracil—Haemorrhage—Methotrexate—breast cancer	0.000283	0.000677	CcSEcCtD
Propylthiouracil—Myalgia—Capecitabine—breast cancer	0.000282	0.000674	CcSEcCtD
Propylthiouracil—Arthralgia—Capecitabine—breast cancer	0.000282	0.000674	CcSEcCtD
Propylthiouracil—TPO—Metabolism—APRT—breast cancer	0.000281	0.000898	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ESRRA—breast cancer	0.000281	0.000898	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ANGPTL4—breast cancer	0.000281	0.000898	CbGpPWpGaD
Propylthiouracil—Oedema—Docetaxel—breast cancer	0.000279	0.000667	CcSEcCtD
Propylthiouracil—Pruritus—Gemcitabine—breast cancer	0.000278	0.000665	CcSEcCtD
Propylthiouracil—Nausea—Thiotepa—breast cancer	0.000278	0.000664	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—DPYD—breast cancer	0.000277	0.000883	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—MED12—breast cancer	0.000277	0.000883	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Epirubicin—breast cancer	0.000276	0.000658	CcSEcCtD
Propylthiouracil—Pruritus—Fluorouracil—breast cancer	0.000274	0.000654	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Docetaxel—breast cancer	0.000273	0.000653	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—breast cancer	0.000273	0.000653	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ALDOA—breast cancer	0.000273	0.00087	CbGpPWpGaD
Propylthiouracil—Oedema—Capecitabine—breast cancer	0.00027	0.000646	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—TNF—breast cancer	0.000269	0.000858	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—breast cancer	0.000268	0.00064	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HADHB—breast cancer	0.000267	0.000851	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GPI—breast cancer	0.000267	0.000851	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL6—breast cancer	0.000267	0.000851	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Epirubicin—breast cancer	0.000266	0.000636	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—breast cancer	0.000266	0.000636	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—breast cancer	0.000265	0.000633	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—breast cancer	0.000265	0.000633	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Capecitabine—breast cancer	0.000265	0.000632	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NCOA3—breast cancer	0.000265	0.000844	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ESRRA—breast cancer	0.000265	0.000844	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ANGPTL4—breast cancer	0.000265	0.000844	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC2A2—breast cancer	0.000263	0.000838	CbGpPWpGaD
Propylthiouracil—Urticaria—Paclitaxel—breast cancer	0.000262	0.000625	CcSEcCtD
Propylthiouracil—Body temperature increased—Paclitaxel—breast cancer	0.00026	0.000622	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ABCG2—breast cancer	0.000257	0.000821	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—MTR—breast cancer	0.000257	0.000821	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CPT1A—breast cancer	0.000257	0.000821	CbGpPWpGaD
Propylthiouracil—Vomiting—Irinotecan—breast cancer	0.000257	0.000613	CcSEcCtD
Propylthiouracil—Vomiting—Mitoxantrone—breast cancer	0.000257	0.000613	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—breast cancer	0.000255	0.000609	CcSEcCtD
Propylthiouracil—Rash—Irinotecan—breast cancer	0.000255	0.000608	CcSEcCtD
Propylthiouracil—Rash—Mitoxantrone—breast cancer	0.000255	0.000608	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ALDH1A1—breast cancer	0.000255	0.000812	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALDH7A1—breast cancer	0.000255	0.000812	CbGpPWpGaD
Propylthiouracil—Dermatitis—Irinotecan—breast cancer	0.000254	0.000608	CcSEcCtD
Propylthiouracil—Dermatitis—Mitoxantrone—breast cancer	0.000254	0.000608	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000254	0.000608	CcSEcCtD
Propylthiouracil—Headache—Mitoxantrone—breast cancer	0.000253	0.000604	CcSEcCtD
Propylthiouracil—Headache—Irinotecan—breast cancer	0.000253	0.000604	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HPGDS—breast cancer	0.000252	0.000805	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HBA1—breast cancer	0.000251	0.0008	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HADHB—breast cancer	0.000251	0.0008	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GPI—breast cancer	0.000251	0.0008	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Docetaxel—breast cancer	0.000251	0.000599	CcSEcCtD
Propylthiouracil—Alopecia—Methotrexate—breast cancer	0.00025	0.000598	CcSEcCtD
Propylthiouracil—Vomiting—Gemcitabine—breast cancer	0.00025	0.000598	CcSEcCtD
Propylthiouracil—Somnolence—Docetaxel—breast cancer	0.000248	0.000593	CcSEcCtD
Propylthiouracil—Rash—Gemcitabine—breast cancer	0.000248	0.000593	CcSEcCtD
Propylthiouracil—Dermatitis—Gemcitabine—breast cancer	0.000248	0.000592	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—breast cancer	0.000246	0.000589	CcSEcCtD
Propylthiouracil—Headache—Gemcitabine—breast cancer	0.000246	0.000589	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000246	0.000588	CcSEcCtD
Propylthiouracil—Vomiting—Fluorouracil—breast cancer	0.000246	0.000588	CcSEcCtD
Propylthiouracil—Dyspepsia—Docetaxel—breast cancer	0.000246	0.000587	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—breast cancer	0.000245	0.000586	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—breast cancer	0.000245	0.000586	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTT1—breast cancer	0.000245	0.000781	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ACHE—breast cancer	0.000245	0.000781	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NME1—breast cancer	0.000244	0.000779	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—UMPS—breast cancer	0.000244	0.000779	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ADSL—breast cancer	0.000244	0.000779	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—FHL2—breast cancer	0.000244	0.000779	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PHGDH—breast cancer	0.000244	0.000779	CbGpPWpGaD
Propylthiouracil—Rash—Fluorouracil—breast cancer	0.000244	0.000583	CcSEcCtD
Propylthiouracil—Dermatitis—Fluorouracil—breast cancer	0.000244	0.000582	CcSEcCtD
Propylthiouracil—Paraesthesia—Capecitabine—breast cancer	0.000243	0.00058	CcSEcCtD
Propylthiouracil—Headache—Fluorouracil—breast cancer	0.000242	0.000579	CcSEcCtD
Propylthiouracil—Dysgeusia—Methotrexate—breast cancer	0.000241	0.000577	CcSEcCtD
Propylthiouracil—Nausea—Mitoxantrone—breast cancer	0.00024	0.000573	CcSEcCtD
Propylthiouracil—Nausea—Irinotecan—breast cancer	0.00024	0.000573	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ALDH1A1—breast cancer	0.000239	0.000763	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALDH7A1—breast cancer	0.000239	0.000763	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—BRIP1—breast cancer	0.000239	0.000763	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HPSE—breast cancer	0.000239	0.000763	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—LDHB—breast cancer	0.000239	0.000763	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—breast cancer	0.000238	0.000759	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Capecitabine—breast cancer	0.000238	0.000568	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—TP53—breast cancer	0.000237	0.000756	CbGpPWpGaD
Propylthiouracil—Alopecia—Epirubicin—breast cancer	0.000234	0.00056	CcSEcCtD
Propylthiouracil—Nausea—Gemcitabine—breast cancer	0.000234	0.000558	CcSEcCtD
Propylthiouracil—Pruritus—Paclitaxel—breast cancer	0.000233	0.000557	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP17A1—breast cancer	0.000232	0.000739	CbGpPWpGaD
Propylthiouracil—Nausea—Fluorouracil—breast cancer	0.00023	0.000549	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ENO1—breast cancer	0.000229	0.000732	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTGS1—breast cancer	0.000229	0.000732	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ADSL—breast cancer	0.000229	0.000732	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PHGDH—breast cancer	0.000229	0.000732	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—UMPS—breast cancer	0.000229	0.000732	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NME1—breast cancer	0.000229	0.000732	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—FHL2—breast cancer	0.000229	0.000732	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HMMR—breast cancer	0.000227	0.000724	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCC1—breast cancer	0.000227	0.000724	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA3—breast cancer	0.000227	0.000724	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Epirubicin—breast cancer	0.000226	0.00054	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP2D6—breast cancer	0.000225	0.000718	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HPSE—breast cancer	0.000225	0.000718	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—LDHB—breast cancer	0.000225	0.000718	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—BRIP1—breast cancer	0.000225	0.000718	CbGpPWpGaD
Propylthiouracil—Vertigo—Methotrexate—breast cancer	0.000222	0.000529	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NCOA2—breast cancer	0.000221	0.000705	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Docetaxel—breast cancer	0.000221	0.000527	CcSEcCtD
Propylthiouracil—Leukopenia—Methotrexate—breast cancer	0.000221	0.000527	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—breast cancer	0.00022	0.000702	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PPARGC1B—breast cancer	0.00022	0.000701	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL6—breast cancer	0.000217	0.000692	CbGpPWpGaD
Propylthiouracil—Alopecia—Doxorubicin—breast cancer	0.000217	0.000518	CcSEcCtD
Propylthiouracil—Urticaria—Capecitabine—breast cancer	0.000215	0.000513	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—FASN—breast cancer	0.000214	0.000683	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Capecitabine—breast cancer	0.000214	0.00051	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—TNF—breast cancer	0.000214	0.000681	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—BCHE—breast cancer	0.000213	0.00068	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCC1—breast cancer	0.000213	0.00068	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HMMR—breast cancer	0.000213	0.00068	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA3—breast cancer	0.000213	0.00068	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC5A5—breast cancer	0.000211	0.000672	CbGpPWpGaD
Propylthiouracil—Myalgia—Methotrexate—breast cancer	0.00021	0.000501	CcSEcCtD
Propylthiouracil—Arthralgia—Methotrexate—breast cancer	0.00021	0.000501	CcSEcCtD
Propylthiouracil—Vomiting—Paclitaxel—breast cancer	0.000209	0.0005	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—breast cancer	0.000209	0.000499	CcSEcCtD
Propylthiouracil—Rash—Paclitaxel—breast cancer	0.000208	0.000496	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CA9—breast cancer	0.000208	0.000662	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA4—breast cancer	0.000208	0.000662	CbGpPWpGaD
Propylthiouracil—Dermatitis—Paclitaxel—breast cancer	0.000207	0.000496	CcSEcCtD
Propylthiouracil—Vertigo—Epirubicin—breast cancer	0.000207	0.000495	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PPARGC1B—breast cancer	0.000207	0.000659	CbGpPWpGaD
Propylthiouracil—Leukopenia—Epirubicin—breast cancer	0.000207	0.000493	CcSEcCtD
Propylthiouracil—Headache—Paclitaxel—breast cancer	0.000206	0.000493	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NQO1—breast cancer	0.000203	0.000649	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC2A1—breast cancer	0.000203	0.000649	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GPX2—breast cancer	0.000202	0.000645	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA2—breast cancer	0.000202	0.000645	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SULT1A1—breast cancer	0.0002	0.000637	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GPX4—breast cancer	0.0002	0.000637	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP3A4—breast cancer	0.000198	0.000633	CbGpPWpGaD
Propylthiouracil—Pruritus—Docetaxel—breast cancer	0.000198	0.000472	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Methotrexate—breast cancer	0.000197	0.000471	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—breast cancer	0.000196	0.000469	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—breast cancer	0.000196	0.000469	CcSEcCtD
Propylthiouracil—Nausea—Paclitaxel—breast cancer	0.000196	0.000467	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP1B1—breast cancer	0.000195	0.000622	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA1—breast cancer	0.000195	0.000622	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—IDH1—breast cancer	0.000195	0.000622	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA4—breast cancer	0.000195	0.000622	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CA9—breast cancer	0.000195	0.000622	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NAT2—breast cancer	0.000193	0.000615	CbGpPWpGaD
Propylthiouracil—Vertigo—Doxorubicin—breast cancer	0.000192	0.000458	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HSP90AA1—breast cancer	0.000191	0.00061	CbGpPWpGaD
Propylthiouracil—Pruritus—Capecitabine—breast cancer	0.000191	0.000457	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—breast cancer	0.000191	0.000457	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GPX2—breast cancer	0.00019	0.000607	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA2—breast cancer	0.00019	0.000607	CbGpPWpGaD
Propylthiouracil—Oedema—Epirubicin—breast cancer	0.000188	0.00045	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GPX4—breast cancer	0.000188	0.000599	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SULT1A1—breast cancer	0.000188	0.000599	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—breast cancer	0.000187	0.000596	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NCOA1—breast cancer	0.000186	0.000594	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Epirubicin—breast cancer	0.000184	0.00044	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP19A1—breast cancer	0.000183	0.000585	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—STK11—breast cancer	0.000183	0.000585	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA1—breast cancer	0.000183	0.000585	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—IDH1—breast cancer	0.000183	0.000585	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000183	0.000438	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—breast cancer	0.000182	0.000434	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—breast cancer	0.000182	0.000434	CcSEcCtD
Propylthiouracil—TPO—Metabolism—NAT2—breast cancer	0.000181	0.000579	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Methotrexate—breast cancer	0.000181	0.000432	CcSEcCtD
Propylthiouracil—Somnolence—Methotrexate—breast cancer	0.000179	0.000427	CcSEcCtD
Propylthiouracil—Vomiting—Docetaxel—breast cancer	0.000178	0.000424	CcSEcCtD
Propylthiouracil—Dyspepsia—Methotrexate—breast cancer	0.000177	0.000423	CcSEcCtD
Propylthiouracil—Rash—Docetaxel—breast cancer	0.000176	0.000421	CcSEcCtD
Propylthiouracil—Dermatitis—Docetaxel—breast cancer	0.000176	0.00042	CcSEcCtD
Propylthiouracil—Headache—Docetaxel—breast cancer	0.000175	0.000418	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—breast cancer	0.000174	0.000416	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL6—breast cancer	0.000172	0.00055	CbGpPWpGaD
Propylthiouracil—Vomiting—Capecitabine—breast cancer	0.000172	0.000411	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000172	0.00041	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—breast cancer	0.000171	0.000408	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—COMT—breast cancer	0.000171	0.000544	CbGpPWpGaD
Propylthiouracil—Rash—Capecitabine—breast cancer	0.00017	0.000407	CcSEcCtD
Propylthiouracil—Dermatitis—Capecitabine—breast cancer	0.00017	0.000407	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTP1—breast cancer	0.00017	0.000541	CbGpPWpGaD
Propylthiouracil—Headache—Capecitabine—breast cancer	0.000169	0.000405	CcSEcCtD
Propylthiouracil—DBH—Metabolism—MED12—breast cancer	0.000169	0.00054	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—DPYD—breast cancer	0.000169	0.00054	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Epirubicin—breast cancer	0.000169	0.000404	CcSEcCtD
Propylthiouracil—Somnolence—Epirubicin—breast cancer	0.000167	0.0004	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HMOX1—breast cancer	0.000167	0.000534	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ITPR1—breast cancer	0.000167	0.000533	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALDOA—breast cancer	0.000167	0.000531	CbGpPWpGaD
Propylthiouracil—Nausea—Docetaxel—breast cancer	0.000166	0.000396	CcSEcCtD
Propylthiouracil—Dyspepsia—Epirubicin—breast cancer	0.000166	0.000396	CcSEcCtD
Propylthiouracil—DBH—Metabolism—NCOA3—breast cancer	0.000162	0.000516	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ABCB1—breast cancer	0.000161	0.000513	CbGpPWpGaD
Propylthiouracil—Nausea—Capecitabine—breast cancer	0.000161	0.000384	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SLC2A2—breast cancer	0.000161	0.000512	CbGpPWpGaD
Propylthiouracil—Urticaria—Methotrexate—breast cancer	0.00016	0.000382	CcSEcCtD
Propylthiouracil—Body temperature increased—Methotrexate—breast cancer	0.000159	0.00038	CcSEcCtD
Propylthiouracil—TPO—Metabolism—DPYD—breast cancer	0.000159	0.000507	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MED12—breast cancer	0.000159	0.000507	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000159	0.000379	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—TYMS—breast cancer	0.000158	0.000503	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCG2—breast cancer	0.000157	0.000502	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CPT1A—breast cancer	0.000157	0.000502	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTR—breast cancer	0.000157	0.000502	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALDOA—breast cancer	0.000157	0.000499	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Doxorubicin—breast cancer	0.000156	0.000374	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PLA2G4A—breast cancer	0.000156	0.000498	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NCOR1—breast cancer	0.000156	0.000498	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTM1—breast cancer	0.000156	0.000498	CbGpPWpGaD
Propylthiouracil—Somnolence—Doxorubicin—breast cancer	0.000155	0.00037	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HPGDS—breast cancer	0.000154	0.000492	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Doxorubicin—breast cancer	0.000153	0.000366	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HBA1—breast cancer	0.000153	0.000489	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOA3—breast cancer	0.000152	0.000485	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC2A2—breast cancer	0.000151	0.000481	CbGpPWpGaD
Propylthiouracil—Urticaria—Epirubicin—breast cancer	0.00015	0.000357	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ACHE—breast cancer	0.00015	0.000477	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTT1—breast cancer	0.00015	0.000477	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GPX1—breast cancer	0.000149	0.000476	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Epirubicin—breast cancer	0.000149	0.000356	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP1A1—breast cancer	0.000148	0.000472	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCG2—breast cancer	0.000148	0.000472	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTR—breast cancer	0.000148	0.000472	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CPT1A—breast cancer	0.000148	0.000472	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ERCC2—breast cancer	0.000147	0.000468	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HPGDS—breast cancer	0.000145	0.000463	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HBA1—breast cancer	0.000144	0.00046	CbGpPWpGaD
Propylthiouracil—Pruritus—Methotrexate—breast cancer	0.000142	0.00034	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP17A1—breast cancer	0.000142	0.000452	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ACHE—breast cancer	0.000141	0.000449	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTT1—breast cancer	0.000141	0.000449	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTGS1—breast cancer	0.00014	0.000447	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ENO1—breast cancer	0.00014	0.000447	CbGpPWpGaD
Propylthiouracil—Urticaria—Doxorubicin—breast cancer	0.000138	0.000331	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—MTHFR—breast cancer	0.000138	0.00044	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Doxorubicin—breast cancer	0.000138	0.000329	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP2D6—breast cancer	0.000137	0.000439	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOA2—breast cancer	0.000135	0.00043	CbGpPWpGaD
Propylthiouracil—Pruritus—Epirubicin—breast cancer	0.000133	0.000318	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CYP17A1—breast cancer	0.000133	0.000425	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS1—breast cancer	0.000132	0.00042	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ENO1—breast cancer	0.000132	0.00042	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—FASN—breast cancer	0.000131	0.000417	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—BCHE—breast cancer	0.00013	0.000416	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2D6—breast cancer	0.000129	0.000412	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC5A5—breast cancer	0.000129	0.000411	CbGpPWpGaD
Propylthiouracil—Vomiting—Methotrexate—breast cancer	0.000128	0.000306	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CAV1—breast cancer	0.000127	0.000406	CbGpPWpGaD
Propylthiouracil—Rash—Methotrexate—breast cancer	0.000127	0.000303	CcSEcCtD
Propylthiouracil—TPO—Metabolism—NCOA2—breast cancer	0.000127	0.000405	CbGpPWpGaD
Propylthiouracil—Dermatitis—Methotrexate—breast cancer	0.000127	0.000303	CcSEcCtD
Propylthiouracil—Headache—Methotrexate—breast cancer	0.000126	0.000301	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SLC2A1—breast cancer	0.000124	0.000397	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NQO1—breast cancer	0.000124	0.000397	CbGpPWpGaD
Propylthiouracil—Pruritus—Doxorubicin—breast cancer	0.000123	0.000295	CcSEcCtD
Propylthiouracil—TPO—Metabolism—FASN—breast cancer	0.000123	0.000392	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—BCHE—breast cancer	0.000123	0.000391	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP3A4—breast cancer	0.000121	0.000387	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC5A5—breast cancer	0.000121	0.000386	CbGpPWpGaD
Propylthiouracil—Vomiting—Epirubicin—breast cancer	0.00012	0.000286	CcSEcCtD
Propylthiouracil—Nausea—Methotrexate—breast cancer	0.00012	0.000286	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP1B1—breast cancer	0.000119	0.00038	CbGpPWpGaD
Propylthiouracil—Rash—Epirubicin—breast cancer	0.000119	0.000284	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—breast cancer	0.000119	0.000283	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—breast cancer	0.000118	0.000282	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HSP90AA1—breast cancer	0.000117	0.000373	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NQO1—breast cancer	0.000117	0.000373	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC2A1—breast cancer	0.000117	0.000373	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CG—breast cancer	0.000116	0.000369	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP3A4—breast cancer	0.000114	0.000364	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOA1—breast cancer	0.000114	0.000363	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—STK11—breast cancer	0.000112	0.000357	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1B1—breast cancer	0.000112	0.000357	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP19A1—breast cancer	0.000112	0.000357	CbGpPWpGaD
Propylthiouracil—Nausea—Epirubicin—breast cancer	0.000112	0.000267	CcSEcCtD
Propylthiouracil—Vomiting—Doxorubicin—breast cancer	0.000111	0.000265	CcSEcCtD
Propylthiouracil—TPO—Metabolism—HSP90AA1—breast cancer	0.00011	0.000351	CbGpPWpGaD
Propylthiouracil—Rash—Doxorubicin—breast cancer	0.00011	0.000262	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—breast cancer	0.00011	0.000262	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—breast cancer	0.000109	0.000261	CcSEcCtD
Propylthiouracil—TPO—Metabolism—NCOA1—breast cancer	0.000107	0.000341	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—STK11—breast cancer	0.000105	0.000336	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP19A1—breast cancer	0.000105	0.000336	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—COMT—breast cancer	0.000104	0.000332	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTP1—breast cancer	0.000104	0.000331	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—breast cancer	0.000103	0.000247	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HMOX1—breast cancer	0.000102	0.000326	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ITPR1—breast cancer	0.000102	0.000325	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CD—breast cancer	0.000102	0.000325	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALB—breast cancer	0.000101	0.000321	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCB1—breast cancer	9.81e-05	0.000313	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—COMT—breast cancer	9.79e-05	0.000312	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTP1—breast cancer	9.75e-05	0.000311	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TYMS—breast cancer	9.64e-05	0.000307	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NOS3—breast cancer	9.61e-05	0.000307	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HMOX1—breast cancer	9.61e-05	0.000307	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ITPR1—breast cancer	9.59e-05	0.000306	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOR1—breast cancer	9.53e-05	0.000304	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PLA2G4A—breast cancer	9.53e-05	0.000304	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTM1—breast cancer	9.53e-05	0.000304	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCB1—breast cancer	9.23e-05	0.000294	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GPX1—breast cancer	9.12e-05	0.000291	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TYMS—breast cancer	9.06e-05	0.000289	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP1A1—breast cancer	9.03e-05	0.000288	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTM1—breast cancer	8.96e-05	0.000286	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PLA2G4A—breast cancer	8.96e-05	0.000286	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOR1—breast cancer	8.96e-05	0.000286	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ERCC2—breast cancer	8.96e-05	0.000286	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—breast cancer	8.87e-05	0.000283	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTGS2—breast cancer	8.79e-05	0.000281	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GPX1—breast cancer	8.58e-05	0.000274	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1A1—breast cancer	8.49e-05	0.000271	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ERCC2—breast cancer	8.42e-05	0.000269	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTHFR—breast cancer	8.42e-05	0.000269	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTHFR—breast cancer	7.92e-05	0.000253	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CAV1—breast cancer	7.77e-05	0.000248	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTEN—breast cancer	7.67e-05	0.000245	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CAV1—breast cancer	7.3e-05	0.000233	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CG—breast cancer	7.07e-05	0.000226	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CG—breast cancer	6.65e-05	0.000212	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—breast cancer	6.22e-05	0.000198	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALB—breast cancer	6.14e-05	0.000196	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NOS3—breast cancer	5.87e-05	0.000187	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—breast cancer	5.85e-05	0.000187	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALB—breast cancer	5.77e-05	0.000184	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NOS3—breast cancer	5.52e-05	0.000176	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—breast cancer	5.42e-05	0.000173	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—breast cancer	5.41e-05	0.000173	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTGS2—breast cancer	5.37e-05	0.000171	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—breast cancer	5.1e-05	0.000163	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS2—breast cancer	5.05e-05	0.000161	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—breast cancer	4.68e-05	0.000149	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—breast cancer	4.42e-05	0.000141	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—breast cancer	4.4e-05	0.000141	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—breast cancer	3.3e-05	0.000105	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—breast cancer	3.11e-05	9.91e-05	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—breast cancer	2.7e-05	8.61e-05	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—breast cancer	2.54e-05	8.1e-05	CbGpPWpGaD
